ストックスクリーナーアプリを入手
1.605
4.55%
0.065
前日終値:
$1.54
開ける：
$1.52
24時間の取引高:
723.67K
Relative Volume:
1.84
時価総額：
$58.69M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+8.78%
1か月 パフォーマンス:
-0.62%
6か月 パフォーマンス:
-57.29%
1年 パフォーマンス:
-56.84%
1日の値動き範囲:
$1.48
$1.62
1週間の範囲:
$1.41
$1.62
52週間の値動き範囲:
$1.23
$5.4999
Metagenomi Inc Stock (MGX) Company Profile
MGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.61 | 58.69M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.01 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
519.97 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.08 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
563.58 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
266.35 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-07 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-03-05 | 開始されました | BMO Capital Markets | Outperform |
| 2024-03-05 | 開始されました | Chardan Capital Markets | Buy |
| 2024-03-05 | 開始されました | JP Morgan | Overweight |
| 2024-03-05 | 開始されました | Jefferies | Buy |
| 2024-03-05 | 開始されました | TD Cowen | Outperform |
| 2024-03-05 | 開始されました | Wells Fargo | Overweight |
すべてを表示
Metagenomi Inc (MGX) 最新ニュース
Metagenomi Requests to Dismiss Class Action Filed by Investors - TradingView
Metagenomi, Inc. (NASDAQ:MGX) Shares Sold by Millennium Management LLC - Defense World
Two Sigma Investments LP Sells 59,135 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi CEO Thomas Brian sells shares worth $18,873 By Investing.com - Investing.com India
Metagenomi CEO Thomas Brian sells shares worth $18,873 - Investing.com
Metagenomi Executives Sell Shares to Cover Tax Obligations - TradingView
Metagenomi Director Irish Jian Sells Shares to Cover Tax Obligations - TradingView
Jane Street Group LLC Invests $107,000 in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Nuveen Asset Management LLC Buys Shares of 63,248 Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi Being Investigated on Behalf of Metagenomi, Inc. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
Adverum Biotechnologies (NASDAQ:ADVM) versus Metagenomi (NASDAQ:MGX) Head-To-Head Analysis - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 11,730 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. (NASDAQ:MGX) Short Interest Down 18.9% in May - Defense World
Citadel Advisors LLC Decreases Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Northern Trust Corp Raises Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
What is HC Wainwright’s Forecast for Metagenomi Q2 Earnings? - Defense World
Equities Analysts Issue Forecasts for Metagenomi Q1 Earnings - Defense World
Metagenomi Inc (NASDAQ: MGX): Finding Hidden Gems Among Volatility - Stocksregister
MGX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Metagenomi, Inc. investment - ACCESS Newswire
Price T Rowe Associates Inc. MD Buys New Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Chardan Capital Has Lowered Expectations for Metagenomi (NASDAQ:MGX) Stock Price - Defense World
Metagenomi, Inc. (NASDAQ:MGX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Yahoo Finance
Voya Investment Management LLC Acquires Shares of 10,314 Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Demystifying Metagenomi: Insights From 4 Analyst Reviews - Benzinga
Chardan Cuts Price Target on Metagenomi to $12 From $13, Keeps Buy Rating - marketscreener.com
Metagenomi, Inc. (NASDAQ:MGX) Shares Bought by Barclays PLC - Defense World
Metagenomi price target lowered to $16 from $20 at Wells Fargo - TipRanks
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing ... - Bluefield Daily Telegraph
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025 - Yahoo Finance
Metagenomi Presents Data Highlighting Advancements in - GlobeNewswire
Metagenomi Reports Business Updates and First Quarter 2025 Financial Results - The Manila Times
Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Metagenomi: Q1 Earnings Snapshot - San Francisco Chronicle
Metagenomi reports Q1 EPS (68c), consensus (51c) - TipRanks
Metagenomi Reports Positive NHP Study Results for Hemophilia A Program and Quarterly Financials - Nasdaq
Metagenomi Q1 Earnings: Breakthrough Hemophilia Treatment Maintains 75% Effectiveness After 19 Months - Stock Titan
Metagenomi (MGX) and Its Competitors Head-To-Head Review - Defense World
Metagenomi (MGX) Projected to Post Earnings on Tuesday - Defense World
Metagenomi, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsMGX - ACCESS Newswire
Metagenomi, Inc. (MGX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire
Levi & Korsinsky Notifies Shareholders of Metagenomi, Inc.(MGX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Wells Fargo & Company MN Increases Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
MGX ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Metagenomi, Inc. - ACCESS Newswire
Metagenomi Being Investigated on Behalf of Metagenomi, Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire
Renaissance Technologies LLC Has $555,000 Stock Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
JPMorgan Chase & Co. Acquires 65,020 Shares of Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi Inc [MGX] stock for 1,744 USD was sold by Wein Matthew - knoxdaily.com
Metagenomi Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Market Update: Metagenomi Inc (MGX) Sees Negative Movement, Closing at 1.49 - DWinneX
Metagenomi to Present at Upcoming Scientific Meetings - GlobeNewswire
Press Release Distribution & PR Platform - ACCESS Newswire
Metagenomi Inc (MGX) 財務データ
Metagenomi Inc (MGX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Metagenomi Inc (MGX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Noonberg Sarah B. | Chief Medical Officer |
Jun 06 '25 |
Sale |
1.75 |
5,239 |
9,168 |
109,135 |
| Wapnick Pamela | Chief Financial Officer |
Jun 06 '25 |
Sale |
1.75 |
1,576 |
2,758 |
72,108 |
| Thomas Brian C. | Chief Executive Officer |
Jun 06 '25 |
Sale |
1.75 |
10,785 |
18,874 |
2,517,491 |
| Irish Jian | See Remarks |
Jun 06 '25 |
Sale |
1.75 |
6,390 |
11,182 |
315,543 |
| Wein Matthew | See Remarks |
Mar 05 '25 |
Sale |
1.87 |
930 |
1,744 |
9,467 |
| Wapnick Pamela | Chief Financial Officer |
Mar 05 '25 |
Sale |
1.87 |
1,808 |
3,390 |
59,684 |
| Wapnick Pamela | Chief Financial Officer |
Dec 05 '24 |
Sale |
1.86 |
1,559 |
2,900 |
61,492 |
| Wapnick Pamela | Chief Financial Officer |
Sep 05 '24 |
Sale |
2.88 |
6,265 |
18,043 |
63,051 |
1.21%
0.67%
大文字化:
|
ボリューム (24 時間):